Kimitoshi Nakamura Selected Research

succinylacetoacetate

9/2022

A case report of two siblings with hypertyrosinemia type 1 presenting with hepatic disease with different onset time and severity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kimitoshi Nakamura Research Topics

Disease

10	Fabry Disease (Fabry's Disease) 12/2022 - 01/2009
8	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2022 - 01/2003
8	Ornithine Carbamoyltransferase Deficiency Disease 11/2021 - 07/2016
7	Inborn Urea Cycle Disorders 12/2021 - 08/2014
7	Inborn Genetic Diseases (Disease, Hereditary) 08/2021 - 01/2003
6	Glycogen Storage Disease Type II (Pompe's Disease) 12/2021 - 07/2009
6	Hyperammonemia 11/2021 - 10/2008
6	Retinal Perforations 02/2021 - 01/2006
5	Tyrosinemias (Tyrosinemia) 09/2022 - 01/2003
5	Gaucher Disease (Gaucher's Disease) 06/2022 - 02/2011
5	Brain Diseases (Brain Disorder) 01/2022 - 07/2015
5	Citrullinemia 11/2021 - 09/2017
5	Intellectual Disability (Idiocy) 07/2021 - 10/2008
4	Acute Liver Failure (Fulminant Hepatic Failure) 09/2022 - 03/2017
4	Inflammation (Inflammations) 01/2022 - 10/2015
4	Disease Progression 01/2022 - 12/2017
4	Epiretinal Membrane (Epiretinal Membranes) 02/2021 - 01/2015
4	Retinal Detachment (Retinal Detachments) 10/2020 - 01/2015
3	Macular Edema 02/2022 - 01/2008
3	Bacterial Infections (Bacterial Infection) 01/2022 - 10/2020
3	Argininosuccinic Aciduria 06/2021 - 01/2021
3	Hyperglycemia 02/2021 - 12/2013
3	Hypoglycemia (Reactive Hypoglycemia) 02/2021 - 12/2002
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 10/2020 - 04/2015
3	Hepatolenticular Degeneration (Wilson's Disease) 07/2019 - 03/2017
2	Liver Failure 09/2022 - 11/2006
2	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 01/2007
2	Hypoxia (Hypoxemia) 02/2022 - 03/2017
2	Hyperargininemia 12/2021 - 01/2021
2	Neurologic Manifestations (Neurological Manifestations) 12/2021 - 04/2019
2	Mucopolysaccharidosis II (Hunter Syndrome) 10/2021 - 01/2021
2	Glucose Intolerance 02/2021 - 01/2019
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 10/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 01/2018
2	Pain (Aches) 07/2019 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 07/2019 - 12/2018
2	Hepatic Encephalopathy 07/2019 - 03/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2019 - 08/2011
2	Cardiac Arrhythmias (Arrythmia) 01/2018 - 07/2007
2	Hemorrhage 01/2018 - 04/2010
2	Hypertension (High Blood Pressure) 01/2017 - 04/2010
2	Liver Neoplasms (Liver Cancer) 01/2017 - 01/2015
2	Methylmalonic acidemia 01/2017 - 12/2016
2	Macular Degeneration (Age-Related Maculopathy) 01/2017 - 09/2002
2	Wounds and Injuries (Trauma) 10/2015 - 01/2003
2	Fibrosis (Cirrhosis) 01/2015 - 01/2006

Drug/Important Bio-Agent (IBA)

11	EnzymesIBA 12/2021 - 10/2008
8	GalactosidasesIBA 12/2022 - 01/2012
6	AmmoniaIBA 11/2021 - 09/2012
6	Amino Acids FDA Link 01/2019 - 11/2006
6	Proteins (Proteins, Gene)FDA Link 04/2017 - 12/2013
5	Retinaldehyde (Retinal)IBA 02/2022 - 01/2008
5	Ligases (Synthetase)IBA 11/2021 - 09/2017
5	Carbamyl Phosphate (Carbamoyl Phosphate)IBA 11/2021 - 08/2014
5	Urea (Carbamide)FDA LinkGeneric 11/2021 - 10/2008
4	Tyrosine (L-Tyrosine)FDA Link 09/2022 - 11/2006
4	Glucosylceramidase (Glucocerebrosidase)IBA 06/2022 - 09/2016
4	ArginaseIBA 12/2021 - 09/2017
3	AntibodiesIBA 02/2022 - 01/2015
3	Collagen Type II (Type II Collagen)IBA 02/2022 - 01/2015
3	ProcalcitoninIBA 01/2022 - 10/2020
3	AcidsIBA 12/2021 - 07/2009
3	GlucosidasesIBA 12/2021 - 05/2011
3	Tryptases (Tryptase)IBA 01/2021 - 01/2015
3	Serine Proteases (Serine Protease)IBA 01/2021 - 01/2015
3	Chymases (Chymase)IBA 01/2021 - 01/2006
3	Chelating AgentsIBA 07/2019 - 03/2017
3	Glycine (Aminoacetic Acid)FDA LinkGeneric 03/2017 - 05/2009
3	CalreticulinIBA 01/2013 - 02/2007
2	nitisinone (Orfadin)FDA Link 09/2022 - 01/2015
2	MicroRNAs (MicroRNA)IBA 02/2022 - 01/2019
2	CytokinesIBA 02/2022 - 01/2019
2	AutoantibodiesIBA 02/2022 - 01/2015
2	C-Reactive ProteinIBA 01/2022 - 01/2021
2	GlycogenIBA 12/2021 - 06/2020
2	Tacrolimus (Prograf)FDA LinkGeneric 11/2021 - 12/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021 - 12/2020
2	SodiumIBA 02/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 01/2019
2	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 01/2021 - 08/2014
2	Argininosuccinate LyaseIBA 01/2021 - 08/2014
2	Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)IBA 01/2021 - 08/2014
2	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2014
2	NitrogenIBA 01/2021 - 08/2014
2	CitrullineIBA 11/2020 - 04/2017
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020 - 01/2018
2	globotriaosylceramide (globotriosylceramide)IBA 01/2020 - 01/2012
2	S-Adenosylmethionine (Ademetionine)IBA 09/2019 - 04/2019
2	CopperIBA 07/2019 - 12/2018
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 10/2015
2	VitaminsIBA 01/2017 - 12/2013
2	CholesterolIBA 04/2015 - 12/2002

Therapy/Procedure

15	Liver Transplantation 09/2022 - 08/2014
14	Therapeutics 09/2022 - 02/2011
7	Renal Dialysis (Hemodialysis) 12/2022 - 01/2009
5	Vitrectomy 02/2021 - 01/2014
3	Hemodiafiltration 09/2022 - 03/2017
3	Enzyme Replacement Therapy 10/2021 - 07/2017
2	Plasma Exchange 09/2022 - 03/2017